301047.SZ
Sino Biological Inc.
SZSE · M 科研服务 · CN
CNY 120.74
+18.96%Oct 28, 2026, 23:50 UTC
Tianxiang Investment Consulting reported that technology and pharmaceutical companies dominated the top 50 stocks newly added to mutual funds’ major holdings by the end of the third quarter of 2026.
Source:Sep 7, 2026, 09:48 UTC
Sino Biological's controlling shareholder Lhasa Ailike Investment Consulting pledged 3.3 million shares to Zhongyuan Trust for financing on September 4, 2026.
Source:Aug 4, 2026, 03:05 UTC
Yiqiao Shenzhou announced the launch of recombinant human full-length, tag-free p-Tau217 protein for the development of Alzheimer's disease biomarker detection.
Source: